QDEL insider trading
NasdaqGS HealthcareQuidelOrtho Corp — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.
About QuidelOrtho Corp
QuidelOrtho Corporation provides diagnostic testing solutions. The company operates through Labs, Transfusion Medicine, Point of Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tests that measure target chemicals in bodily fluids for the evaluation of health and the clinical management of patients; immunoassay laboratory instruments and tests, to measure proteins as they act as antigens in the spread of disease, antibodies in the immune response spurred by disease, or markers of proper organ function and health; testing to detect and monitor disease progression across a spectrum of therapeutic areas; and specialized diagnostic solutions. The Transfusion Medicine business unit offers immunohematology instruments and tests used for blood typing to ensure patient-donor compatibility in blood transfusions; and donor screening instruments and tests used for blood and plasma screening for infectious diseases. The Point of Care business unit provides instruments and tests to provide rapid results across a continuum of POC settings. The Molecular Diagnostics business unit offers polymerase chain reaction thermocyclers; amplification systems; and sample-to-result molecular instruments and tests for syndromic infectious disease diagnostics. The company sells its products directly to end users through a direct sales force; and through a network of distributors for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies, wellness screening centers, blood banks, and donor centers, as well as for individual, non-professional, and over-the-counter use. It operates in North America, Europe, the Middle East, Africa, China, Japan and Asia Pacific, and Latin America. The company was incorporated in 1979 and is headquartered in San Diego, California.
Company website: www.quidelortho.com
QDEL insider activity at a glance
FilingIQ has scored 1,473 insider transactions for QDEL since Jan 19, 2015. The most recent filing in our index is dated Apr 26, 2026.
Across the full history, 21 open-market purchases
and 288 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
The average FilingIQ composite score on QDEL insider trades is 61.8/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.
Latest QDEL Form 4 filings
Most recent disclosures. Sign up to filter by score, transaction code, or insider role.
Other Healthcare tickers with recent insider activity
Top insiders trading QDEL
13F funds holding QDEL
Frequently asked
- How many insider trades does FilingIQ track for QDEL?
- FilingIQ tracks 1,473 Form 4 insider transactions for QDEL (QuidelOrtho Corp), covering filings from Jan 19, 2015 onwards. 17 of those were filed in the last 90 days.
- Are QDEL insiders net buyers or net sellers?
- Across the full Form 4 history for QDEL, 21 transactions (1%) were open-market purchases and 288 (20%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does QDEL insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
- What sector is QDEL in?
- QuidelOrtho Corp (QDEL) is classified in the Healthcare sector, specifically Medical Devices, with a current market capitalisation of $1.44B.
Methodology & sources
Every QDEL insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.